r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

KM

Kevin F. McLaughlin

Insider · Director · VCEL

Kevin F. McLaughlin files insider transactions with the SEC as a director of Vericel (VCEL). We hold 3 disclosed purchases and sales filed since 5 September 2006, 1 of them in the last 90 days.

  • Files forVCEL
  • Disclosed buys and sells3 in all, 1 in the last 90 days
  • Last disclosure14 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 March 2015 — 12 August 2026Director · Vericel (VCEL)73 Form 4 lines · source: SEC Form 4
  • Filed 21 May 2024 — 19 May 2026Director · Invivyd (IVVD)4 Form 4 lines · source: SEC Form 4
  • Filed 10 October 2022 — 25 September 2023Director · Decibel Therapeutics (DBTX)6 Form 4 lines · source: SEC Form 4
  • Filed 5 December 2013 — 19 November 2021SVP, CFO and Treasurer · Acceleron Pharma (XLRN)291 Form 4 lines · source: SEC Form 4
  • Filed 1 September 2006 — 8 February 2007President and CEO · Praecis Pharmaceuticals (PRCS)4 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.